The success of Viagra initially drove a period of growth for pharma, but recent shifts present a murky picture for shareholders. Lower-cost alternatives are eroding profits, and persistent litigation add additional https://jeandjze542090.blog-ezine.com/41735601/sildenafil-and-pharma-a-precarious-bet